Search

Search Constraints

You searched for: Subject Mogamulizumab

Search Results

1. Macrophage-derived CXCL9 and CXCL11 recruit CD8 T cells in skin and provide long-term disease control in mogamulizumab-treated CTCL patients. (October 2021)